A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study

BACKGROUND: Currently, although several categories of biological disease-modifying antirheumatic drugs (bDMARDs) are available, there are few data informing selection of initial treatment for individual patients with rheumatoid arthritis (RA). Therefore, tumor necrosis factor inhibitor (TNF-i) and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Jin, Koyama, Yoshinobu, Kawakami, Atsushi, Ueki, Yukitaka, Tsukamoto, Hiroshi, Horiuchi, Takahiko, Nagano, Shuji, Uchino, Ayumi, Ota, Toshiyuki, Akahoshi, Mitsuteru, Akashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553584/
https://www.ncbi.nlm.nih.gov/pubmed/28800780
http://dx.doi.org/10.1186/s13075-017-1387-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553584/
https://www.ncbi.nlm.nih.gov/pubmed/28800780
http://dx.doi.org/10.1186/s13075-017-1387-9

Ejemplares similares